Login/Sign Up
Buvalor 5 mcg/h Transdermal Patch 2's
Buvalor 5 mcg/h Transdermal Patch is primarily used to treat pain. It contains 'Buprenorphine', an opioid partial agonist-antagonist. It works by blocking a chemical messenger in the brain that is responsible for causing pain. This provides pain relief by acting on specific receptors in the brain. Common side effects of Buvalor 5 mcg/h Transdermal Patch are drowsiness, dry mouth, vomiting, blurred vision, constipation, application site reactions, dizziness, or tiredness.
₹782.1*
MRP ₹869
10% off
₹738.65*
MRP ₹869
15% CB
₹130.35 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Buvalor 5 mcg/h Transdermal Patch belongs to a class of drugs called 'opioid analgesics' primarily used to treat, prevent and treat severe pain. Pain can be temporary (acute) or long-lasting (chronic) in nature. Acute pain is caused by damage to the tissues of the muscle, bone, or other organs for a short time. Chronic pain lasts for a long duration and is caused due to pathologies like nerve damage and osteoarthritis.
Buvalor 5 mcg/h Transdermal Patch contains 'Buprenorphine', an opioid partial agonist-antagonist. It works by blocking a chemical messenger in the brain responsible for causing pain. This provides pain relief by acting on specific receptors in the brain.
Use Buvalor 5 mcg/h Transdermal Patch as advised by your doctor. You may experience certain side effects in some cases, including drowsiness, dry mouth, vomiting, blurred vision, constipation, application site reactions, dizziness or tiredness. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Buvalor 5 mcg/h Transdermal Patch should be avoided if you are allergic to it or any of its ingredients or opioids. Do not use Buvalor 5 mcg/h Transdermal Patch if you are pregnant or breastfeeding. Buvalor 5 mcg/h Transdermal Patch is not recommended for children below 18 years of age. Buvalor 5 mcg/h Transdermal Patch is a habit-forming drug; hence, there is a risk of dependence. Do not stop using this medicine without consulting your doctor, as it may cause withdrawal symptoms like anxiety, increased heart rate, tremors or general unwell feelings. Buvalor 5 mcg/h Transdermal Patch may decrease fertility in men and women. Do not consume alcohol while using Buvalor 5 mcg/h Transdermal Patch as it may increase the risk of side effects.
The Buvalor 5 mcg/h Transdermal Patch contains Buprenorphine. It provides pain relief by acting on specific receptors in the brain and helps in relieving pain. Compared to other opioid analgesics like methadone, Buvalor 5 mcg/h Transdermal Patch has the advantage of having less sedation (sleepiness), decreased respiratory depression, decreased risk of diversion, fewer withdrawal symptoms and lower risk of toxicity at higher doses.
Please do not stop using Buvalor 5 mcg/h Transdermal Patch suddenly, as it may cause withdrawal symptoms. Avoid frequent or high doses as it may lead to addiction. If you are known to be allergic to Buvalor 5 mcg/h Transdermal Patch or any other medicines, please tell your doctor. Do not use Buvalor 5 mcg/h Transdermal Patch if you are pregnant or breastfeeding, as it may cause adverse effects on the baby. Buvalor 5 mcg/h Transdermal Patch is not recommended for children below 18 years of age. Avoid consuming alcohol with Buvalor 5 mcg/h Transdermal Patch as it may increase the risk of side effects. Do not use this medicine if you have used an MAO inhibitor (antidepressants) in the past 14 days, as a dangerous drug interaction could occur. Buvalor 5 mcg/h Transdermal Patch should be taken with extreme caution in patients who have a history of alcoholism or drug abuse. Inform your doctor if you have severe breathing problems, asthma, delirium tremens (confusion and shaking after stopping drinking alcohol), hallucinations (seeing and hearing things that are not there), kidney or liver problems, head injury or brain disease, low blood pressure, urinary disorders (especially linked to enlarged prostate), thyroid problems, adrenocortical disorder (Addison’s disease), depression or other conditions that are treated with antidepressants.
Drug-Drug Interactions: Buvalor 5 mcg/h Transdermal Patch may have interaction with benzodiazepines (diazepam, temazepam ), pain killers (pentazocine, nalbuphine, codeine, dihydrocodeine, methadone, morphine), anti-depressants (moclobemide, tranylcypromine, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, amitriptyline, doxepin, trimipramine), antihistamine (promethazine, chlorphenamine), blood thinners (warfarin), anti-anxiety drugs (alprazolam), fits related medicines (carbamazepine), medicines used to prevent nausea (ondansetron), antifungal drugs (ketoconazole), antibiotic (ciprofloxacin, erythromycin), anticancer drugs (ceritinib, lapatinib), immunosuppressants (fingolimod), antipsychotics (droperidol), and HIV/AIDS drugs (saquinavir).
Drug-Food Interactions: Buvalor 5 mcg/h Transdermal Patch may interact with grapefruit juice. Therefore, avoid grapefruit juice intake with Buvalor 5 mcg/h Transdermal Patch, as it may increase Buvalor 5 mcg/h Transdermal Patch levels in the body. Also, avoid St. John's wort (an antidepressant plant) and alcohol consumption while using Buvalor 5 mcg/h Transdermal Patch, as they may increase the risk of adverse effects such as drowsiness, dizziness, and difficulty concentrating.
Drug-Disease Interactions: People with asthma or any other breathing problems, kidney problems, liver problems, head injury or brain disease, low blood pressure, urinary disorders (especially linked to enlarged prostate), thyroid problems, adrenocortical disorder (Addison’s disease), depression should consult a doctor before using Buvalor 5 mcg/h Transdermal Patch.
Pain: It can be short-term (acute) or long-term (chronic) in nature. Acute pain is, for a short time, caused by damage to the tissues of the muscle, bone, or organs. Chronic pain lasts for a longer duration and is caused by pathologies like nerve damage, osteoarthritis, and dental pain due to damage to the tooth nerve, infection, decay, extraction, or injury. Many women have painful periods known as dysmenorrhea, most often menstrual cramps. On the other hand, Osteoarthritis is a degenerative disease that results in chronic pain in joints (especially knee) and stiffness, making daily tasks difficult.
Alcohol
Unsafe
Consuming alcohol or other illicit drugs during treatment with Buvalor 5 mcg/h Transdermal Patch increases your chances of experiencing these significant, life-threatening adverse effects. Throughout your therapy, do not consume alcohol, use alcohol-containing prescription or nonprescription medicines, or use street drugs.
Pregnancy
Unsafe
If you are pregnant or planning pregnancy, inform your doctor. If you use Buvalor 5 mcg/h Transdermal Patch often throughout your pregnancy, your baby may suffer from potentially fatal withdrawal symptoms after birth. If your infant exhibits any of the following symptoms, contact your doctor straight away: irritability, hyperactivity, disturbed sleep, high-pitched scream, excessive shaking of a portion of the body, vomiting, diarrhoea, or failure to gain weight.
Breast Feeding
Unsafe
If you are nursing, you should avoid using Buvalor 5 mcg/h Transdermal Patch. Buprenorphine passes into breast milk in small amounts and might cause respiratory issues in your infant. Talk with your doctor; they may prescribe a different pain reliever.
Driving
Unsafe
Buvalor 5 mcg/h Transdermal Patch may cause dizziness, blurred vision or drowsiness in some people. Therefore, avoid driving if you feel drowsy, dizzy or experience any vision problems after using Buvalor 5 mcg/h Transdermal Patch.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before using Buvalor 5 mcg/h Transdermal Patch.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before using Buvalor 5 mcg/h Transdermal Patch.
Children
Unsafe
Buvalor 5 mcg/h Transdermal Patch is not recommended for children below 18 years of age as safety and effectiveness have not been established.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
Product Substitutes